North Carolina surgery center hit hard by lidocaine shortage — 3 insights

Raleigh (N.C.) Skin Surgery Center is suffering from a shortage of injectable lidocaine with epinephrine, which is in short supply despite being manufactured just 47 miles away, local news affiliate CBS17.com reports.

Advertisement

What you should know:

1. Lidocaine has been in short supply since March 2017. In August 2017, Raleigh Skin Surgery Center was down to a two-week supply. Center physician Tamara Housman, MD, said the surgery center was calling hospitals and pharmacies in search of lidocaine.

2. A Pfizer spokesperson said the company was aware of the shortages and that it was working to fulfill back orders, but the company did not explain why lidocaine was in short supply.

3. Dr. Housman criticized the FDA’s drug shortage webpage, which lists lidocaine as both “available” and under a “manufacturing delay.” A web page to that linked to a letter from Pfizer to customers is broken.

“The practice would absolutely have to shut down if we didn’t have it,” said Dr. Housman

More articles on surgery centers: 
American Pain Society considers bankruptcy — 4 details
NAPA anesthesiologists win national performance accolade — 4 details
Viewpoint: How payers are suppressing anesthesia payments — 3 observations 

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Beyond the bottleneck: How health systems are improving access, flow and care continuity

Thursday, July 30
1:00 PM - 2:00 PM CDT

Presenters: Imamu Tomlinson, MD, MBA, VituityWilliam Morice II, MD, PhD, Mayo Clinic LaboratoriesJordan Dale, MD, Houston MethodistAsh Tengshe, City of HopeChris Klay, MHA, MA, PT, FACHE, Hospital Sisters Health System

Advertisement

Next Up in Supply chain

Advertisement

Comments are closed.